PATENT CLAIM ANALYSIS

Application Number: 16132440
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "468000"]

Abstract:
The present invention provides a composition including an amphiphilic compound capable of self-assembling into a liquid crystalline phase; and a niacin compound. In another aspect, the present invention provides a method for the treatment of a disease state comprising administering a therapeutically effective amount of a pharmaceutical composition incorporating that composition

Claim (Index 38):
The method of  claim 30 , wherein administering the composition comprises nighttime administration.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14889878', '13132880', '11665776', '12233337', '12935819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6874277565802502
- 35 USC 102 Novelty (BERT): 0.5551395993711178
- Combined Prediction Score: 0.674198940859337
- Mean Citation Score: 264.979396
- Max Citation Score: 635.5089
- Similarity Product: 255.75015594198703

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test